RegCell
Business Services · 51-200 Employees
View Company Info for Free
Overview
Website
www.regcell.jpRevenue
$8 MillionIndustry
About RegCell
RegCell Org Chart
Is RegCell your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if RegCell has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once RegCell has new funding data
Product Launch: Get notified when RegCell launches new products
Click to see if RegCell had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
RegCell, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on RegCell recently announced quarterly report
Check out if RegCell is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at RegCell
Recommended Actions
Reach out to Masked Content who joined RegCell as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
RegCell is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
RegCell is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about RegCell.
RegCell Tech Stack
A closer look at the technologies used by RegCell
RegCell News & Media
RegCell Scientific Founder and Board Member Dr. Shimon Sakaguchi Awarded Nobel Prize in Physiology or Medicine
EMERYVILLE, Calif., Oct. 9, 2025 /PRNewswire/ -- RegCell, Inc. a biotechnology company developing first-in-class therapies for autoimmune diseases and transplantation with its epigenetic reprogramming platform leveraging the natural biology of regulatory T cells (Tregs), proudly announced...Japanese-Founded Regulatory T-cell Reprogramming Company RegCell Secures $45.8M ...
Funding includes $8.5M from an oversubscribed seed financing with up to $37.3M in non-dilutive investment from The Japan Agency for Medical Research and...RegCell Appoints Experienced Life Science Executive and Entrepreneur Michael McCullar, Ph.D., MBA, as its New Chief Executive Officer
OSAKA, Japan, Oct. 19, 2023 /PRNewswire/ -- RegCell, a biotechnology company developing novel therapies for autoimmune diseases by leveraging the natural biology of regulatory T cells (Tregs) with its next-generation cell reprogramming platform, today announced the appointment of Michael...Collaborators at the Keio and Osaka Universities Present Key Non-Clinical Data with Stable/Functional-Induced Regulatory T Cells (S/F-iTregs) in Autoimmune Disease Models
OSAKA, Japan, May 29, 2023 /PRNewswire/ -- RegCell collaborators from Keio University and Osaka University presented key data at ISID 2023 Tokyo Satellite Meeting. Their presentation demonstrated that in a murine pemphigus model, S/F-iTregs significantly decreased clinical scores,...
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding RegCell
レグセル株式会社 specializes in innovative immune system control technologies utilizing regulatory T cells. The company focuses on developing advanced solutions for immune modulation. Their products and services are aimed at clients in the healthcare and biotechnology sectors. The company is committed to enhancing immune responses through cutting-edge rese... Read More